The impact on outcomes from cancer surgery of the COVID-19 pandemic

The NHS must ensure cancer-surgery delays do not cost more lives than the number of Covid-19 patients saved | Annals of Oncology

  • Lockdown and re-deployment due to the COVID-19 pandemic is causing significant disruption to cancer diagnosis and management.
  • 3-month delay to surgery across all Stage 1-3 cancers is estimated to cause >4,700 attributable deaths per year in England.
  • The impact on life years lost of 3-6 month to surgery for Stage 1-3 disease varies widely between tumour types.
  • Strategic prioritisation of patients for diagnostics and surgery has potential to mitigate deaths attributable to delays.
  • The resource-adjusted benefit in avoiding delay in cancer management compares favourably to admission for COVID-19 infection.

Full article: Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic | Annals of Oncology (2020)

See also: Coronavirus: Cancer surgery delays risk ‘thousands’ of deaths | BBC News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s